Keith Meister, Corvex Management's chief investment officer, will join Illumina's board starting March 28. He's no stranger ...

Illumina expects to reach a growth rate in its revenues of 6%-9% CAGR by 2027. See why I think ILMN stock is an appealing ...

At the same time, Keith Meister, managing partner and chief investment officer of the hedge fund Corvex Management, will take ...

Illumina Inc. added activist investor Keith Meister to its board and elevated director Scott Gottlieb, a former head of the ...

Activist investor Keith Meister will join the board of gene-sequencing maker Illumina , and current board member Scott ...

Activist investor Keith Meister will join the board of directors of troubled gene-sequencing maker Illumina and current board member Scott Gottlieb will become chairman. The moves, which the ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced changes to its Board of Directors. Scott Gottlieb, MD, has been elected non-executive ...

Struggling gene-sequencing machine and chemical company Illumina (ILMN) has fallen further into the hands of activist investors. Keith ...

Beijing banned imports of Illumina’s gene-sequencing machines in response to U.S. tariffs.

The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the gene-sequencing company from importing its machines to the country.

Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS) technology with annual revenue of $4.37 billion, finds itself at a critical juncture as it navigates a shifting ...

Gene-sequencing giant Illumina is laying off 96 employees from its San Diego headquarters, according to paperwork filed with the state. This workforce reduction comes at a time when Illumina is ...